Agentic AI Is Forcing Healthcare to Confront a New Kind of Risk
Atos is framing agentic AI as a major opportunity for health and life sciences, but the category raises difficult questions about autonomy, accountability, and control. The more AI systems can act on their own, the more healthcare has to decide where automation should stop.
Agentic AI is one of the most consequential ideas in healthcare technology because it shifts AI from recommendation to action. Instead of merely generating answers, these systems can initiate steps, coordinate tasks, and potentially make multi-stage decisions across fragmented workflows.
That capability is attractive in healthcare and life sciences because so much operational friction comes from handoffs. But the same autonomy that makes agentic systems powerful also makes them harder to supervise, harder to audit, and harder to reverse when something goes wrong.
The challenge is not just technical; it is organizational. Healthcare institutions need clear rules about who approves actions, what thresholds trigger escalation, and how to log the sequence of decisions if a downstream problem occurs. Without that structure, agency becomes liability.
If agentic AI succeeds, it may automate some of healthcare’s most tedious processes. But the category will only earn trust if vendors can prove that autonomy enhances outcomes without creating invisible chains of responsibility that clinicians and patients cannot see.